Oct. 14, 2022
by Andrii Buvailo
Interview
In contrast to molecular mechanics, which describes molecules as essentially “balls and sticks” kind of objects, taking into account only …
Oct. 11, 2022
by Andrii Buvailo, Natalia Honchar
Biopharma insight
Over the past decade, Canada emerged as a promising global location for drug discovery and biotech business, especially when it …
Oct. 8, 2022
by Andrii Buvailo, Bohdana Sokolova
Biopharma insight
In August, Pfizer announced it requested to join VitaDAO with a half-a-million bid. VitaDAO is a new type of decentralized …
Oct. 7, 2022
Case study
Sponsored by Arctoris
Arctoris is driven by a relentless pursuit to make drug discovery better. An industry where bringing a single drug to …
Oct. 5, 2022
by Irina Bilous, Andrii Buvailo
Biopharma insight
(Last updated: October 05, 2022) The interest of pharma organizations in DNA-encoded chemical libraries (DEL) technology has been growing over …
There are many drug target classes for which unwanted on-target pharmacology limits clinical application. Understanding E3 tissue expression across both …
A key step in the targeted protein degradation (TPD) process is the formation of an induced proximity complex, where a …
In contrast to the discovery of "traditional drugs" such as small molecule inhibitors and most biologics, the development of protein …
Sept. 7, 2022
by Andrii Buvailo
Biopharma insight
Sponsored by Chemspace
The concept of deoxyribonucleic acid (DNA)-encoded chemical libraries was invented three decades ago, but only recently it has become a …
Sept. 2, 2022
by Bohdana Sokolova
Biopharma insight
According to the World Health Organisation, cancer is a leading cause of death worldwide, accounting for nearly 10 million deaths …
Aug. 30, 2022
by Andrii Buvailo
Biopharma insight
Disclaimer: This post is not medical advice and is for informational purposes only. All the information contained here is related …
Aug. 25, 2022
by Bohdana Sokolova
Biopharma insight
Even though the term ‘synthetic biology’ remains foreign to an average person, the idea behind it is familiar to many. …